Evidence map›Paper›PMID 40379112›Full record

ReviewMatrix biology : journal of the International Society for Matrix Biology2025

Interactions between cancer-associated fibroblasts and the extracellular matrix in oesophageal cancer.

Subashan Vadibeler, Shannique Clarke, Su M Phyu, Eileen E Parkes

Abstract readReview
In one paragraph

Review in Matrix biology : journal of the International Society for Matrix Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Subashan VadibelerCentre for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford, United Kingdom; Department of Oncology, University of Oxford, United Kingdom.
Shannique ClarkeCentre for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford, United Kingdom; Department of Oncology, University of Oxford, United Kingdom.
Su M PhyuDepartment of Oncology, University of Oxford, United Kingdom.
Eileen E ParkesCentre for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford, United Kingdom; Department of Oncology, University of Oxford, United Kingdom. Electronic address: eileen.parkes@oncology.ox.ac.uk.

Funding

Wellcome Trust 224623
6 · The paper itself

Abstract

Stromal components of the tumour microenvironment, such as cancer-associated fibroblasts (CAFs) and the extracellular matrix (ECM), are actively involved in tumorigenesis. CAFs and the ECM co-evolve with resultant molecular and mechanical pressure on tumour cells mediated by CAFs via the ECM. Meanwhile, ECM fibers determine CAF differentiation and activity, establishing a protumorigenic feed-forward loop. Oesophageal cancer carries a high morbidity and mortality, and curative surgical resection is only an option for a limited number of patients while early lymphatic spread and poor therapeutic responses are common. Although studies report marked heterogeneity in investigation of the stromal density of gastrointestinal cancers, it is generally accepted that oesophageal cancer is highly fibrotic, and stromal components like CAFs may outnumber cancer cells. Therefore, a comprehensive understanding of the reciprocal interaction between CAFs and the ECM in oesophageal cancer is essential to improving diagnostics and prognostication, as well as designing innovative anti-cancer strategies. Here, we summarise current understanding of oesophageal cancer from a stromal perspective. Then, we discuss that CAFs and the ECM in oesophageal cancer can independently and synergistically contribute to tumour progression and therapeutic resistance. We also summarise potential stromal targets that have been described in transcriptomic analyses, highlighting those validated in downstream experimental studies. Importantly, clinical translation of stromal-targeting strategies in oesophageal cancer is still in its infancy but holds significant promise for future therapeutic combinations.

Indexed as

Cancer-Associated FibroblastsEsophageal NeoplasmsExtracellular MatrixAnimalsGene Expression Regulation, NeoplasticHumansTumor MicroenvironmentCancer-associated fibroblastsExtracellular matrixFibrosisOesophageal adenocarcinomaOesophageal cancerOesophageal squamous cell carcinomaTumour stroma

Identifiers

PMID40379112
PMCPMC7617858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.